FDA Approves neffy® for Emergency Treatment of Allergic Reactions
Here’s what you need to know NEWS: On August 9, 2024, the U.S. Food and Drug Administration approved neffy® (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are life threatening (anaphylaxis), in adult…